Ticker Details
Cogent Biosciences, Inc.
IPO Date:	March 26, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.06B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 3.11%
Avg Daily Range (30 D):	$0.61 | 1.71%
Avg Daily Range (90 D):	$0.74 | 1.98%

Institutional Daily Volume
Avg Daily Volume:	.72M
Avg Daily Volume (30 D):	1.82M
Avg Daily Volume (90 D):	1.83M

Trade Size
Avg Trade Size (Sh.):	101
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	2,722
Avg Institutional Trade:	$2.16M
Avg Institutional Trade (30 D):	$4.42M
Avg Institutional Trade (90 D):	$3.6M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.13M
Avg Closing Trade (30 D):	$14.21M
Avg Closing Trade (90 D):	$12.75M
Avg Closing Volume:	212.96K

News

Mar 21, 2026 @ 11:13 PM This $116 Million Buy Joins a 360% Stock Run and S... Source: Jonathan Ponciano

Mar 20, 2026 @ 4:07 PM Biotech Stock Up 372% Gets Sold as New Pick Rises ... Source: Jonathan Ponciano

Mar 16, 2026 @ 4:42 PM Cogent Biosciences Stock Climbs After FDA Accepts ... Source: Vandana Singh

Feb 28, 2026 @ 2:45 PM Cogent Biosciences Highlights Additional Data with... Source: Na

Feb 10, 2026 @ 1:00 PM Cogent Biosciences Announces Multiple SUMMIT Poste... Source: Not Specified

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.16	$-.61	$-2.16
Diluted EPS	$-2.16	$-.61	$-2.16
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-328.94M	$-102.49M	$-328.94M
Operating Income / Loss	$-333.36M	$-99.49M	$-333.36M
Cost of Revenue
Net Cash Flow	$214.26M	$186.8M	$214.26M
PE Ratio

Splits
Nov 09, 2020	1:4